News & Analysis as of

National Defense Authorization Act › Prescription Drugs

The National Defense Authorization Act is a United States federal statute enacted each year to specify the budget and expenditures of the Department of Defense. The NDAA identifies which agencies are responsible... more +
The National Defense Authorization Act is a United States federal statute enacted each year to specify the budget and expenditures of the Department of Defense. The NDAA identifies which agencies are responsible for national defense, provides funding for those agencies and includes instructions on proper use of the funds.  less -
Fenwick & West LLP

Update on the BioSecure Act

Fenwick & West LLP on

The BioSecure Act is a bipartisan bill introduced in both the U.S. House of Representatives and Senate earlier this year that would effectively stop companies that are doing business with the U.S. government from using...more

Cozen O'Connor

Cozen Currents: The Inseparable Line Between Governing and Campaigning

Cozen O'Connor on

The Cozen Lens- • Members of Congress have returned to Washington with a lengthy to-do list. Most pressing is appropriations given the potential for a government shutdown at the end of this month. Lawmakers will address...more

Sheppard Mullin Richter & Hampton LLP

At a Glance: White House 100-Day Supply Chain Report

Sheppard Mullin Richter & Hampton LLP on

In February 2021, President Biden issued Executive Order 14017, “Executive Order on America’s Supply Chains” (discussed here), requiring (among other things) a report within 100-days requiring key government agencies to...more

Wilson Sonsini Goodrich & Rosati

Discontinuance and Interruptions in Manufacturing During COVID-19

Wilson Sonsini Goodrich & Rosati on

On March 31, 2020, the United States Food and Drug Administration (FDA) issued guidance surrounding notification procedures if a manufacturer suffers a permanent discontinuance or interruption in manufacturing under the...more

Clark Hill PLC

Window On Washington - Vol. 3, Issue 47

Clark Hill PLC on

Outlook for This Week in the Nation’s Capital - Appropriations. All signs are currently positive that the appropriations process will wrap up in time to meet the December 20 deadline....more

Akin Gump Strauss Hauer & Feld LLP

What's New in Washington - September 2019

Akin Gump Strauss Hauer & Feld LLP on

Congress returns to D.C. this week for a short three-week sprint to a series of important deadlines on September 30. Chief among them is funding the federal government for Fiscal Year (FY) 2020 which begins on October 1,...more

Sheppard Mullin Richter & Hampton LLP

TRICARE: Defense Health Agency Issues Request for Information Regarding Formulary Management – Submission Deadline: February 5,...

Sheppard Mullin Richter & Hampton LLP on

The Defense Health Agency (DHA), which manages the TRICARE health care benefits, has issued a Request for Information (RFI) regarding inpatient-clinic administered pharmaceuticals formulary management. In other words,...more

Clark Hill PLC

Window On Washington - Vol. 2, Issue 32

Clark Hill PLC on

Outlook for This Week in the Nation's Capital - Appropriations. The Senate is expected to begin work this week on its next minibus appropriations bill- a package that would contain the Defense and Labor-HHS spending bills....more

Clark Hill PLC

Window On Washington - Vol. 2, Issue 21

Clark Hill PLC on

Outlook for This Week in the Nation's Capital - Recess Week. Both the House and Senate are in recess this week. Opioid Legislation. Majority Leader McCarthy has said that the House is planning to consider its expansive...more

Hogan Lovells

New Legislation Increases Access to Medical Products for Military Applications

Hogan Lovells on

Yesterday, the President signed new legislation that gives the Department of Defense (DoD) new opportunities to advocate to FDA for expedited development, review, and Emergency Use Authorization (EUA) for medical products...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide